دورية أكاديمية

Multi-omic rejuvenation of human cells by maturation phase transient reprogramming.

التفاصيل البيبلوغرافية
العنوان: Multi-omic rejuvenation of human cells by maturation phase transient reprogramming.
المؤلفون: Gill D; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom., Parry A; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom., Santos F; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom., Okkenhaug H; Imaging Facility, Babraham Institute, Cambridge, United Kingdom., Todd CD; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom., Hernando-Herraez I; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom., Stubbs TM; Chronomics Limited, London, United Kingdom., Milagre I; Laboratory for Epigenetic Mechanisms/Chromosome Dynamics Lab, Instituto Gulbenkian de Ciência, Oeiras, Portugal., Reik W; Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.; Centre for Trophoblast Research, University of Cambridge, Cambridge, United Kingdom.
المصدر: ELife [Elife] 2022 Apr 08; Vol. 11. Date of Electronic Publication: 2022 Apr 08.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Cambridge, UK : eLife Sciences Publications, Ltd., 2012-
مواضيع طبية MeSH: Induced Pluripotent Stem Cells* , Rejuvenation*, Cellular Reprogramming/genetics ; DNA Methylation ; Epigenome ; Epigenomics/methods ; Fibroblasts ; Humans ; Middle Aged
مستخلص: Ageing is the gradual decline in organismal fitness that occurs over time leading to tissue dysfunction and disease. At the cellular level, ageing is associated with reduced function, altered gene expression and a perturbed epigenome. Recent work has demonstrated that the epigenome is already rejuvenated by the maturation phase of somatic cell reprogramming, which suggests full reprogramming is not required to reverse ageing of somatic cells. Here we have developed the first "maturation phase transient reprogramming" (MPTR) method, where reprogramming factors are selectively expressed until this rejuvenation point then withdrawn. Applying MPTR to dermal fibroblasts from middle-aged donors, we found that cells temporarily lose and then reacquire their fibroblast identity, possibly as a result of epigenetic memory at enhancers and/or persistent expression of some fibroblast genes. Excitingly, our method substantially rejuvenated multiple cellular attributes including the transcriptome, which was rejuvenated by around 30 years as measured by a novel transcriptome clock. The epigenome was rejuvenated to a similar extent, including H3K9me3 levels and the DNA methylation ageing clock. The magnitude of rejuvenation instigated by MPTR appears substantially greater than that achieved in previous transient reprogramming protocols. In addition, MPTR fibroblasts produced youthful levels of collagen proteins, and showed partial functional rejuvenation of their migration speed. Finally, our work suggests that optimal time windows exist for rejuvenating the transcriptome and the epigenome. Overall, we demonstrate that it is possible to separate rejuvenation from complete pluripotency reprogramming, which should facilitate the discovery of novel anti-ageing genes and therapies.
Competing Interests: DG, AP, FS, HO, CT, IH, IM No competing interests declared, TS is CEO and shareholder of Chronomics, WR is a consultant and shareholder of Cambridge Epigenetix. Is employed by Altos Labs
(© 2022, Gill et al.)
References: J Biol Chem. 2003 Dec 5;278(49):49448-58. (PMID: 12972431)
Cell. 2005 Oct 21;123(2):347-58. (PMID: 16239150)
Mol Cell. 2013 Jan 24;49(2):359-367. (PMID: 23177740)
Genes Dev. 2011 Nov 1;25(21):2248-53. (PMID: 22056670)
Genome Biol. 2018 Dec 20;19(1):221. (PMID: 30567591)
J Biol Chem. 2014 Mar 7;289(10):6899-6907. (PMID: 24451367)
Cell. 2015 Jul 16;162(2):412-424. (PMID: 26186193)
Genes Cells. 2012 May;17(5):337-43. (PMID: 22487104)
Aging Cell. 2022 Mar;21(3):e13578. (PMID: 35235716)
Nat Commun. 2020 Mar 24;11(1):1545. (PMID: 32210226)
Aging Cell. 2019 Feb;18(1):e12877. (PMID: 30450724)
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2115-9. (PMID: 1549570)
Nature. 2020 Dec;588(7836):124-129. (PMID: 33268865)
Cell. 2013 Jun 6;153(6):1194-217. (PMID: 23746838)
Cell. 2012 Dec 21;151(7):1617-32. (PMID: 23260147)
Aging (Albany NY). 2018 Apr 18;10(4):573-591. (PMID: 29676998)
Lab Invest. 2017 Oct;97(10):1152-1157. (PMID: 28530648)
Cell. 2012 Jan 20;148(1-2):46-57. (PMID: 22265401)
Aging (Albany NY). 2018 Oct 21;10(10):2832-2854. (PMID: 30348905)
Cell Stem Cell. 2010 Jul 2;7(1):64-77. (PMID: 20621051)
Clin Epigenetics. 2018 Oct 16;10(1):123. (PMID: 30326963)
Genome Biol. 2016 Oct 3;17(1):205. (PMID: 27716309)
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. (PMID: 17194761)
Aging Cell. 2021 Mar;20(3):e13320. (PMID: 33656257)
Development. 2007 Jan;134(2):273-84. (PMID: 17121810)
Cell. 2014 Feb 13;156(4):663-77. (PMID: 24529372)
Nat Rev Mol Cell Biol. 2014 Dec;15(12):802-12. (PMID: 25355505)
Cell Rep. 2017 Jan 31;18(5):1079-1089. (PMID: 28147265)
J Tissue Viability. 2011 Nov;20(4):108-20. (PMID: 19995679)
Development. 2000 Jan;127(2):307-17. (PMID: 10603348)
Genome Biol. 2014 Feb 03;15(2):R24. (PMID: 24490752)
Aging (Albany NY). 2017 Mar 28;9(3):1055-1068. (PMID: 28373601)
J Cell Biol. 1993 Jul;122(1):265-78. (PMID: 7686164)
Genome Biol. 2017 Apr 11;18(1):68. (PMID: 28399939)
Nat Commun. 2015 Oct 22;6:8570. (PMID: 26490707)
Hum Mol Genet. 2014 Oct 15;23(20):5402-17. (PMID: 24852372)
Nat Struct Mol Biol. 2010 Oct;17(10):1218-25. (PMID: 20890289)
J Cell Biol. 1994 Mar;124(5):855-63. (PMID: 8120105)
Mol Cell. 2019 May 2;74(3):542-554.e5. (PMID: 30905509)
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12426-31. (PMID: 25097266)
Nat Aging. 2022 Mar;2(3):243-253. (PMID: 37118377)
Nat Biotechnol. 2015 Jan;33(1):58-63. (PMID: 25437882)
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3038-43. (PMID: 24516164)
Science. 2006 May 19;312(5776):1059-63. (PMID: 16645051)
Nat Rev Genet. 2005 Dec;6(12):893-904. (PMID: 16341070)
Cell. 2016 Dec 15;167(7):1719-1733.e12. (PMID: 27984723)
Elife. 2022 Apr 08;11:. (PMID: 35390271)
Aging (Albany NY). 2019 Jan 21;11(2):303-327. (PMID: 30669119)
Cell Stem Cell. 2009 Feb 6;4(2):141-54. (PMID: 19200803)
Dev Biol. 2005 Nov 1;287(1):48-60. (PMID: 16182275)
Genome Biol. 2015 Mar 24;16:56. (PMID: 25887522)
Cell. 2007 Nov 30;131(5):861-72. (PMID: 18035408)
Aging Cell. 2012 Apr;11(2):315-25. (PMID: 22212395)
Stem Cell Res. 2014 May;12(3):754-61. (PMID: 24735951)
Aging (Albany NY). 2019 Aug 18;11(16):5895-5923. (PMID: 31422385)
Nature. 2013 Oct 17;502(7471):340-5. (PMID: 24025773)
Cancer Res. 2021 Nov 15;81(22):5666-5677. (PMID: 34385183)
Genome Res. 2018 Jan;28(1):122-131. (PMID: 29208628)
Aging (Albany NY). 2018 Jul 26;10(7):1758-1775. (PMID: 30048243)
Genome Biol. 2013;14(10):R115. (PMID: 24138928)
Sci Adv. 2021 Jun 25;7(26):. (PMID: 34172448)
Cell Stem Cell. 2008 Sep 11;3(3):346-353. (PMID: 18786421)
Curr Biol. 2003 Jul 1;13(13):1116-21. (PMID: 12842010)
PLoS One. 2019 Jul 3;14(7):e0219165. (PMID: 31269075)
Am J Pathol. 2006 Jun;168(6):1861-8. (PMID: 16723701)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; 210754/Z/18/Z United Kingdom WT_ Wellcome Trust; 215912/Z/19/Z United Kingdom WT_ Wellcome Trust; United Kingdom BB_ Biotechnology and Biological Sciences Research Council
فهرسة مساهمة: Keywords: DNA methylation; ageing; genetics; genomics; human; regenerative medicine; rejuvenation; reprogramming; stem cells; transcription
سلسلة جزيئية: GEO GSE165180; GSE113957; GSE107654; GSE54848; GSE110544
تواريخ الأحداث: Date Created: 20220407 Date Completed: 20220425 Latest Revision: 20240216
رمز التحديث: 20240216
مُعرف محوري في PubMed: PMC9023058
DOI: 10.7554/eLife.71624
PMID: 35390271
قاعدة البيانات: MEDLINE
الوصف
تدمد:2050-084X
DOI:10.7554/eLife.71624